innoscripta SE (ISIN: DE000A40QVM8) has expanded into the United Kingdom, marking its second international market entry following its launch in France earlier this year. The German-based company has established a local sales team and already secured its first UK customer, a software company with annual revenues in the mid-double-digit million euro range. The customer has selected innoscripta's SaaS platform Clusterix, adapted to UK regulatory requirements, to support its R&D tax relief claims.
Clusterix enables companies to systematically capture R&D projects, working hours, and eligible costs, creating a comprehensive, audit-ready documentation trail. This capability is increasingly critical as HM Revenue & Customs (HMRC) has tightened documentation and compliance requirements for R&D tax relief claims in recent years. The platform's ability to provide robust documentation gives companies a significant advantage in navigating these stricter regulations.
With annual R&D tax reliefs of approximately EUR 8.7 billion (about 0.3% of GDP), the United Kingdom represents a market roughly seven times larger than Germany and is one of Europe's largest R&D tax incentive markets alongside France. innoscripta's expansion into the UK opens up significant growth opportunities, as the company plans to substantially expand both its UK sales organization and customer base by the end of the year. Several additional customer engagements are already at advanced stages of negotiation.
The UK market entry follows innoscripta's successful launch in France, as announced in a news release dated 15 April 2026. The company's international expansion strategy leverages its expertise in R&D tax incentive markets, where automated solutions like Clusterix help companies manage complex compliance requirements efficiently. As R&D tax relief regimes evolve across Europe, innoscripta's platform addresses the growing need for digitized, transparent, and scalable R&D management.
innoscripta SE offers Clusterix as a scalable software platform for the structured organization and management of research and development activities. Companies use Clusterix to efficiently manage innovation projects, digitize internal processes, and make their R&D activities transparent and scalable. The platform's adaptation to UK regulatory requirements demonstrates innoscripta's commitment to localizing its solutions for different markets.
